Blog – Page 31 – PRAIS 2.0

Home
Blog

PAHO and German Development Agency GIZ sign agreement to advance regional health priorities, with special focus on digital transformation

admin - 19:08, 29 de May de 2024244

PAHO and German Development Agency GIZ sign agreement to advance regional health priorities, with special focus on digital transformation

Cristina Mitchell

30 May 2024

Tobacco and nicotine industry tactics addict youth for life

admin - 16:22, 29 de May de 2024260

Tobacco and nicotine industry tactics addict youth for life

Cristina Mitchell

30 May 2024

FDA’s Reorganization Approved for Establishing Unified Human Foods Program, New Model for Field Operations and Other Modernization Efforts

Murilo Freitas - 15:28, 29 de May de 2024187

FDA’s Reorganization Approved for Establishing Unified Human Foods Program, New Model for Field Operations and Other Modernization Efforts
http://www.fda.gov/news-events/press-announcements/fdas-reorganization-approved-establishing-unified-human-foods-program-new-model-field-operations-and

OptumHealth Care Solutions Recalls Nimbus II Infusion Pump Systems Under Recall by InfuTronix, LLC

Murilo Freitas - 04:00, 29 de May de 2024200

Nimbus II infusion pumps may experience one or more issues that can cause severe patient injury and death.

http://www.fda.gov/medical-devices/medical-device-recalls/optumhealth-care-solutions-recalls-nimbus-ii-infusion-pump-systems-under-recall-infutronix-llc

Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Docetaxel Injection, USP Due to Potential Presence of Particulate Matter

Murilo Freitas - 04:00, 28 de May de 2024193

Sagent Pharmaceuticals today announced the voluntary nationwide recall of two lots of Docetaxel Injection, USP (80 mg per 8 mL multi-dose vials and 160 mg per 16 mL multi-dose vials). The product was distributed by Sagent Pharmaceuticals. Sagent has initiated this voluntary recall of Docetaxel Injec

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/sagent-pharmaceuticals-issues-voluntary-nationwide-recall-docetaxel-injection-usp-due-potential

FDA Approves First Interchangeable Biosimilar for Two Rare Diseases

Murilo Freitas - 22:06, 27 de May de 2024283

FDA Approves First Interchangeable Biosimilar for Two Rare Diseases
http://www.fda.gov/news-events/press-announcements/fda-approves-first-interchangeable-biosimilar-two-rare-diseases

Ministers and high-level health authorities of the Americas discuss future pandemic response

admin - 21:02, 27 de May de 2024230

Ministers and high-level health authorities of the Americas discuss future pandemic response

Cristina Mitchell

28 May 2024

OPS llama a abordar las inequidades en el acceso a la salud sexual y reproductiva

admin - 20:04, 27 de May de 2024215

PAHO calls for addressing inequities in access to sexual and reproductive health care

Cristina Mitchell

28 May 2024

FDA Roundup: May 28, 2024

Murilo Freitas - 19:39, 27 de May de 2024195

FDA Roundup: May 28, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-may-28-2024

PAHO and Unitaid strengthen partnership to eliminate communicable diseases from the Americas

admin - 18:47, 26 de May de 2024221

PAHO and Unitaid strengthen partnership to eliminate communicable diseases from the Americas

Cristina Mitchell

27 May 2024

PRAIS 2.0